Neuroprotective agents for the treatment of acute ischemic stroke

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current Neurology and Neuroscience Reports

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11910-003-0031-ZPMID 12507405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diazepam to Improve Acute Stroke Outcome: Results of the Early GABA-Ergic Activation Study In Stroke Trial

  2006cited by this paper
• Magnetic Resonance in Intravenous Magnesium Efficacy in Stroke Trial

  2004cited by this paper
• Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants.

  2002cited by this paper
• Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results

  2002cited by this paper
• Acetaminophen for Altering Body Temperature in Acute Stroke: A Randomized Clinical Trial

  2002cited by this paper
• Neuroprotective Effect of Delayed Moderate Hypothermia After Focal Cerebral Ischemia: An MRI Study

  2002cited by this paper
• Neuroprotection is unlikely to be effective in humans using current trial designs.

  2002cited by this paper
• Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

  2002cited by this paper
• Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

  2002cited by this paper
• NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death

  2002cited by this paper
• Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal cerebral ischemia in rats.

  2002cited by this paper
• Orolingual angioedema after alteplase treatment of stroke is associated with angiotensin converting enzyme inhibitor use

  2002cited by this paper
• Organised stroke care increases the numbers and the speed with which patients with acute ischemic stroke are thrombolysed

  2002cited by this paper
• Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review

  2001cited by this paper
• Tirilazad for acute ischaemic stroke.

  2001cited by this paper
• Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

  2001cited by this paper
• Calcium Antagonists for Ischemic Stroke: A Systematic Review

  2001cited by this paper
• Recommendations for Clinical Trial Evaluation of Acute Stroke Therapies

  2001cited by this paper
• Trends in Acute Ischemic Stroke Trials Through the 20th Century

  2001cited by this paper
• Endovascular Cooling for Moderate Hypothermia in Patients With Acute Stroke: First Results of a Novel Approach

  2001cited by this paper
• Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.

  2001cited by this paper
• Magnesium for Neuroprotection in Ischaemic Stroke

  2001cited by this paper
• Have Randomized Controlled Trials of Neuroprotective Drugs Been Underpowered?: An Illustration of Three Statistical Principles

  2001cited by this paper
• [Experimental study of pharmacological hypothermia: enhanced neuroprotective effect of a novel 5-HT 1 A agonist SUN N4057 by the pharmacological hypothermia].

  2001cited by this paper
• Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1

  2001cited by this paper
• Design of NAALADase inhibitors: a novel neuroprotective strategy.

  2001cited by this paper
• Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.

  2001cited by this paper
• Gangliosides for acute ischaemic stroke.

  2001cited by this paper
• Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole

  2001cited by this paper
• The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T)

  2001cited by this paper
• Potential of anticytokine therapies in central nervous system ischaemia

  2001cited by this paper
• Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.

  2001cited by this paper
• The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke

  2001cited by this paper
• Very early nimodipine use in stroke (VENUS): A randomized, double-blind, placebo-controlled trial.:

  2001cited by this paper
• EGASIS - Early GABA-ergic Activation Study In Stroke. A multicentre, randomised, placebo-controlled, double blind trial to evaluate the use of diazepam in the acute phase of stroke

  2001cited by this paper
• Stroke Therapy Academic Industry Roundtable. Recommendations for clinical trial evaluation of acute stroke therapies.

  2001cited by this paper
• Piracetam for acute ischaemic stroke.

  2000cited by this paper
• Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study: The Copenhagen Stroke Study

  2000cited by this paper
• Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury

  2000cited by this paper
• Phase II Clinical Trial of Sipatrigine (619C89) by Continuous Infusion in Acute Stroke

  2000cited by this paper
• Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.

  2000cited by this paper
• Gangliosides for acute ischaemic stroke.

  2000cited by this paper
• Neuroprotection by the Inhibition of Apoptosis

  2000cited by this paper
• ω-Agatoxin IVA-sensitive Ca2+ channel blocker, α-eudesmol, protects against brain injury after focal ischemia in rats

  2000cited by this paper
• Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

  2000cited by this paper
• Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.

  2000cited by this paper
• Why do neuroprotective drugs work in animals but not humans?

  2000cited by this paper
• Neuroprotection and the Ischemic Cascade

  2000cited by this paper
• Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial [ISRCTN19943732]

  2000cited by this paper
• Diazepam Treatment to Increase the Cerebral GABAergic Activity in Acute Stroke: A Feasibility Study in 104 Patients

  2000cited by this paper
• Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

  2000cited by this paper
• Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS).

  2000cited by this paper
• Mechanisms of action of neuroprotectants in stroke.

  2000influential reference
• omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats.

  2000cited by this paper
• Neuroprotection in Acute Ischaemic Stroke

  1999cited by this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke

  1999cited by this paper
• Which targets are relevant for therapy of acute ischemic stroke?

  1999cited by this paper
• Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.

  1999cited by this paper
• Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.

  1999cited by this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

  1999cited by this paper
• Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

  1999cited by this paper
• Calcium in ischemic cell death.

  1998cited by this paper
• Effects of Intracellular Calcium Reduction by Dantrolene on Prevention/Treatment of Ischemic Stroke

  1998cited by this paper
• Infarction Moderate Hypothermia in the Treatment of Patients With Severe Middle Cerebral Artery

  1998cited by this paper
• Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.

  1998cited by this paper
• Cerestat and other NMDA antagonists in ischemic stroke

  1997cited by this paper
• Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group.

  1995cited by this paper
• Safety, Tolerability, and Pharmacokinetics of the N-Methyl-d-Aspartate Antagonist Dextrorphan in Patients With Acute Stroke

  1995cited by this paper
• Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy

  1995cited by this paper
• Reduction of Central Nervous System Reperfusion Injury in Rabbits Using Doxycycline Treatment

  1994cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper

• Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies

  2025cites this paper
• A new taxonomy of neuroprotective agents for stroke appropriate for the reperfusion era

  2025cites this paper
• An Evaluation Model for Brain Ischemia Protection in Mice by Low-Intensity Pulsed Ultrasound Stimulation Based on Functional Cortico-Muscular Coupling

  2025cites this paper
• Diarylheptanoid-flavanone adducts from Alpinia officinarum and their neuroprotective activities.

  2025cites this paper
• Challenges and Potential of Artificial Intelligence in Neuroradiology

  2024cites this paper
• Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy

  2024cites this paper
• Oxygen-loaded microbubble-mediated sonoperfusion and oxygenation for neuroprotection after ischemic stroke reperfusion

  2023cites this paper
• Selective homing of brain-derived reconstituted lipid nanoparticles to cerebral ischemic area enables improved ischemic stroke treatment.

  2023cites this paper
• Therapeutic management of ischemic stroke

  2023cites this paper
• The initiator of neuroexcitotoxicity and ferroptosis in ischemic stroke: Glutamate accumulation

  2023cites this paper
• Quantifying the amount of greater brain ischemia protection time with pre-hospital vs. in-hospital neuroprotective agent start

  2022influential citation
• Is Bilirubin Associated with the Severity of Ischemic Stroke? A Dose Response Meta-Analysis

  2022cites this paper
• A New Paradigm for Neuroprotection Clinical Trials for Acute Ischemic Stroke

  2022cites this paper
• Principles of Neural Repair and Their Application to Stroke Recovery Trials

  2021cites this paper
• Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

  2021cites this paper
• Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage

  2021cites this paper
• LncRNA DANCR attenuates brain microvascular endothelial cell damage induced by oxygen-glucose deprivation through regulating of miR-33a-5p/XBP1s

  2020cites this paper
• Cell Biology International

  2020cites this paper
• Особенности нарушения световой чувствительности сетчатки у больных с хронической ишемией головного мозга в зависимости от стадии дисциркуляторной энцефалопатии на фоне применения нейропептида

  2020cites this paper
• Neuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury

  2019cites this paper
• ACUTE ISCHEMIC STROKE; CORRELATION BETWEEN SERUM CALCIUM LEVELS AND SEVERITY OF INFARCT IN PATIENTS.

  2018cites this paper
• Preconditioning of Human Neural Stem Cells with Metformin to Promote Post-Stroke Recovery

  2018cites this paper
• Potential application value of xenon in stroke treatment

  2018cites this paper
• Intake of potassium- and magnesium-enriched salt improves functional outcome after stroke: a randomized, multicenter, double-blind controlled trial.

  2017cites this paper
• History of Neuroprotection: Trials and Tribulations

  2017cites this paper
• Erythropoietin: Endogenous Protection of Ischemic Brain.

  2017cites this paper
• The Ischemic Penumbra: Correlates in Imaging and Implications for Treatment of Ischemic Stroke

  2016cites this paper
• 59 – Interventions to Improve Recovery after Stroke

  2016cites this paper
• Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke

  2016cites this paper
• Protective Effects of Danshen on Cerebral Vessels and the Nervous System

  2015cites this paper
• Activation of large-conductance Ca(2+)-activated K(+) channels inhibits glutamate-induced oxidative stress through attenuating ER stress and mitochondrial dysfunction.

  2015cites this paper
• Antenatal Magnesium Sulfate for Neuroprotective Effects In Preterm Infants

  2014cites this paper
• Phosphorylation enhances recombinant HSP27 neuroprotection against focal cerebral ischemia in mice.

  2014cites this paper
• Magnesium: Potential Roles in Neurovascular Disease

  2014cites this paper
• Novel approach to the role of NMDA receptors in traumatic brain injury.

  2014cites this paper
• Effects of elevated magnesium and substrate on neuronal numbers and neurite outgrowth of neural stem/progenitor cells in vitro.

  2014cites this paper
• Magnesium – more than a common cation

  2013cites this paper
• Neuroprotective agents in ischemic stroke: past failures and future opportunities

  2013cites this paper
• Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke.

  2013cites this paper
• Fluoxetine-Induced Cortical Adult Neurogenesis

  2013cites this paper
• Drug-Like Property Profiling of Novel Neuroprotective Compounds to Treat Acute Ischemic Stroke: Guidelines to Develop Pleiotropic Molecules

  2013cites this paper
• The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.

  2013cites this paper
• The 2012 Feinberg Lecture: treatment swift and treatment sure.

  2013cites this paper
• Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury

  2013cites this paper
• Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke.

  2013cites this paper
• Investigation of Magnesium-based Interventions for Central and Peripheral Nervous Tissue Regeneration

  2013cites this paper
• Transient ischemic attack and stroke in systemic lupus erythematosus

  2013cites this paper
• Epidermal growth factor and growth hormone-releasing peptide-6: Combined therapeutic approach in experimental stroke

  2013cites this paper
• Emerging neuroprotective drugs for the treatment of acute ischaemic stroke

  2013cites this paper
• Examining the potential of PGE₂ receptor EP₄ as a neuroprotective target following ischaemic injury

  2013cites this paper
• Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection in Preterm Infants

  2013cites this paper
• Antenatal magnesium individual participant data international collaboration: Assessing the benefits for babies using the best level of evidence (AMICABLE)

  2012cites this paper
• Repair-Based Therapies After Stroke

  2012cites this paper
• Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: dose response and time window.

  2012cites this paper
• Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs

  2012cites this paper
• Novel multi-functional nitrones for treatment of ischemic stroke.

  2012cites this paper
• The role of glutamate in neuronal ischemic injury: the role of spark in fire

  2012cites this paper
• Neuroprotection for Stroke: Current Status and Future Perspectives

  2012cites this paper
• Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE)

  2012cites this paper
• Neuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside

  2012cites this paper
• Neuroprotection in experimental stroke with targeted neurotrophins

  2011cites this paper
• Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery

  2011cites this paper
• Neanthes japonica (Iznka) fibrinolytic enzyme reduced cerebral infarction, cerebral edema and increased antioxidation in rat models of focal cerebral ischemia.

  2011cites this paper
• A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

  2011cites this paper
• An overview of therapies to promote repair of the brain after stroke

  2011cites this paper
• The Ischemic Penumbra: Correlates in Imaging and Implications for Treatment of Ischemic Stroke

  2011cites this paper
• The Mechanisms of Neuroprotection by Melatonin in Cerebral Ischaemia Reperfusion

  2011cites this paper
• Diagnostic Strategies in CEREBRAL ISCHEMIA Diagnostic Strategies in CEREBRAL

  2011cites this paper
• Therapeutic Angiogenesis for Vascular Diseases

  2011cites this paper
• The orally combined neuroprotective effects of sodium ferulate and borneol against transient global ischaemia in C57 BL/6J mice

  2010cites this paper
• Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia

  2010cites this paper
• Neuroprotective effect of 5,7,3',4',5'-pentahydroxy dihydroflavanol-3-O-(2''-O-galloyl)-beta-D-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat.

  2010cites this paper
• Spectral Doppler optical coherence tomography imaging of localized ischemic stroke in a mouse model.

  2010cites this paper
• Targeting the Brain: Neuroprotection and Neurorestoration in Ischemic Stroke

  2010cites this paper
• Cerebral tissue repair and atrophy after embolic stroke in rat: A magnetic resonance imaging study of erythropoietin therapy

  2010cites this paper
• Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery

  2010cites this paper
• Possible Neuroprotective Effects of Magnesium Sulfate and Melatonin as Both Pre- and Post-Treatment in a Neonatal Hypoxic-Ischemic Rat Model

  2010cites this paper
• Safe and Effective Vascular Endothelial Cell Growth Factor (VEGF)-based Therapeutic Angiogenesis for Ischemic Stroke: Insights from Preclinical Trials

  2010cites this paper
• Cerebrovascular disease in dogs and cats.

  2010cites this paper
• Emerging drugs for acute ischemic stroke

  2009cites this paper
• The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans

  2009cites this paper
• Apoptosis and Necrosis in Brain: Contribution of Glycerophospholipid, Sphingolipid, and Cholesterol-Derived Lipid Mediators

  2009cites this paper
• Ischaemic and haemorrhagic stroke in the dog.

  2009cites this paper
• Emerging drugs for acute ischemic stroke.

  2009cites this paper
• Early Neutrophilia Is Associated With Volume of Ischemic Tissue in Acute Stroke

  2008cites this paper
• Repairing the human brain after stroke. II. Restorative therapies

  2008cites this paper
• Serum Calcium as Prognosticator in Ischemic Stroke

  2008cites this paper
• AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils

  2008cites this paper
• Association of serum bilirubin with ischemic stroke outcomes.

  2008cites this paper
• Neuroprotection for ischemic stroke: past, present and future.

  2008cites this paper
• Translocation and neuroprotective properties of transactivator‐of‐transcription protein‐transduction domain–neuroglobin fusion protein in primary cultured cortical neurons

  2008cites this paper
• Antenatal magnesium sulphate neuroprotection in the preterm infant.

  2007cites this paper
• Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke Trials

  2007influential citation
• Optimising Clinical Trial Design for Proof of Neuroprotection in Acute Ischaemic Stroke: The SAINT Clinical Trial Programme

  2006cites this paper
• A Cerebroprotective Dose of Intravenous Citrate/Sorbitol-stabilized Dehydroascorbic Acid is Correlated with Increased Cerebral Ascorbic Acid and Inhibited Lipid Peroxidation after Murine Reperfused Stroke

  2006cites this paper
• Are elevated admission calcium levels associated with better outcomes after ischemic stroke?

  2006cites this paper
• Neuroprotective Agents for the Treatment of Ischemic and Hemorrhagic Stroke

  2006cites this paper
• Apoptosis: Future Targets for Neuroprotective Strategies

  2006cites this paper
• Neuroprotection – STAIR-Way to the Future?

  2006cites this paper
• Akuter Schlaganfall - Reperfusion als primäres Therapieprinzip

  2006cites this paper